// App-Quantinova.ai

S219 : MATRIX FOLLOWED BY AUTOLOGOUS TRANSPLANT IS ASSOCIATED WITH EXCELLENT SURVIVAL AND NEUROTOLERABILITY IN PRIMARY CNS LYMPHOMA: RESULTS OF THE IELSG32 TRIAL AT A MEDIAN FOLLOW-UP OF 88 MONTHS

Researchers

Presenter

  • Gerald Illerhaus

Principal Investigators

  • Elisa Pulczynski

  • Christopher Fox

  • Elisabeth Schorb

  • Claudia Celico

  • Monica Falautano

  • Alessandro Nonis

  • Paul La Rose

  • Mascha Binder

  • Alberto Fabbri

  • Fiorella Ilariucci

  • Mauro Krampera

  • Alexander Rth

  • Claire Hemmaway

  • Peter W M Johnson

  • Kim Linton

  • Tobias Pukrop

  • Jette Snderskov Grlv

  • Monica Balzarrotti

  • Georg Hess

  • Ulrich Keller

  • Stephan Stilgenbauer

  • Jens Panse

  • Alessandra Tucci

  • Lorella Orsucci

  • Francesco Pisani

  • Manuela Zanni

  • Stefan Krause

  • Hans Joachim Schmoll

  • Bernd Hertenstein

  • Mathias Rummel

  • Jeffery Smith

  • Lorenz Thurner

  • Maria Giuseppina Cabras

  • Elsa Pennese

  • Maurilio Ponzoni

  • Martina Deckert

  • Letterio Politi

  • Jrgen Finke

  • Antonella Ferranti

  • Kelly Cozens

  • Elvira Burger

  • Nicoletta Ielmini

  • Franco Cavalli

  • Emanuele Zucca

  • Andrs J.M. Ferreri

Medical Centers

  • Division of Experimental Oncology,IRCCS San Raffaele Scientific Institute,Milan,Italie

  • UK NCRI Lymphoma Group,Southampton General Hospital,Southampton,United Kingdom

  • Centro diagnosi e terapia dei linfomi,Presidio Ospedaliero Spirito Santo,Pescara,Italy

  • S.C. Ematologia,Istituto Regina Elena,Roma,Italy

  • Klinik für Hämatologie/Onkologie,Martin-Luther Universität,Halle,Germany

  • Projektkoordination Klinische Studien,Universitätsklinikum Freiburg,Freiburg,Germany

  • A.O.U. Citta della Salute e della Scienza di Torino, Torino, Italy

  • Klinik für Innere Medizin II,Schwarzwald-Baar Klinikum,VILLINGEN-SCHWENNINGEN,Germany

  • Innere Medizin I, Universitaetsklinikum des Saarlandes, Homburg/Saar, Germany

  • Unità Operativa di Oncologia Medica,IRCCS San Raffaele Scientific Institute,Milano,Italy

  • Arcispedale S. Maria Nuova Azienda Ospedaliera di Reggio Emilia, Reggio Emilia, Italy

  • Southampton Clinical Trials Unit,University of Southampton, Southampton, United Kingdom

  • Divisione di ematologia,Policlinico G.B. Rossi,Verona,Italy

  • Department of Haematology UCLH, Informazioni di sicurezza sul COVID-19 University College London Hospitals NHS Foundation Trust,lLondon,United Kingdom

  • Fondazione Italiana Linfomi,Alessandria,Italy

  • Manchester Cancer Research Centre, University of Manchester, Manchester, United Kingdom

  • Neuro-Oncology Unit-IRCCS San Raffaele Scientific Institute, Milan, Italy

  • I. Medizinische Klinik, Klinikum Bremen-Mitte, Bremen, Germany

  • Klinikum der Landeshauptstadt Stuttgart gKAöR

  • Klinik fur Innere Medizin II, Universitatsklinikum Jena, Jena, Germany

  • USD Sezione Ematologia,Spedali Civili,Brescia,Italy

  • Zentrum für Onkologie,Universitätskrankenhaus Hamburg-Eppendorf - UKE,Hamburg,Germany

  • Klinik fur Innere Medizin II, Universitatsklinikum Jena, Jena, Germany

  • Standort Mitte, Katharinenhospital,Klinik für Hämatologie, Onkologie und Palliativmedizin,Stuttgart,Germany

  • Klinik für Hämatologie und Stammzelltransplantation,Universitätsmedizin Essen (AöR),Essen,Germany

  • Unità di Neuroriabilitazione,IRCCS San Raffaele Scientific Institute,Milan,Italy

  • Medizinische Klinik und Poliklinik, Universitatsmedizin Mainz, Mainz, Germany

  • Klinik für Innere Medizin IV,Universitätsklinikum Aachen,Aachen,Germany

  • Medizinische Klinik 5, Universitaetsklinikum Erlangen, Erlangen, Germany

  • Department of Hematology, Rigshospitalet, Copenhagen, Denmark

  • University Hospital Aintree, Liverpool, United Kingdom

  • Haematopathology Diagnostic Area,IRCCS San Raffaele Scientific Institute,Milano,Italy

  • UOC Ematologia e trapianti,Azienda ospedaliera universitaria senese,Siena,Italy

  • S.C. Ematologia, A.O. SS. Antonio e Biagio e C. Arrigo, Alessandria, Italy

  • Klinik für Innere Medizin,Universitätsklinikum Ulm,Ulm,Germany

  • Universitatsklinikum Regensburg, Regensburg, Germany

  • Queen's Hospital Romford, London, England, United Kingdom

  • Clinical Haematology City Campus,Nottingham University Hospitals NHS Trust,Nottingham,United Kingdom

  • Department of Hematology, Aarhus University Hospital, Aarhus, Denmark

  • Medizinische Klinik IV,Klinikum der Justus-Liebing-Universität,Giessen,Germany

  • University Centre for Statistics in the Biomedical Sciences,IRCCS San Raffaele Scientific Institute,Milan,Italy

  • Department of Neuropathology, University of Bonn, Bonn, Germany

  • Anatomopathology, Humanitas Research Hospital, Rozzano, Italy

  • International Extranodal Lymphoma Study Group,Institute of Oncology Research,Bellinzona,Switzerland

  • III. Medizinischen Klinik des Klinikums rechts der Isar,Technische Universität München,München,Germany

  • Unità Operativa di Ematologia,Ospedale A. Businco,Cagliari,Italy

Locations

  • Italy

  • United Kingdom

  • Germany

  • Denmark

  • Switzerland

Companies

  • N/A

Study Components

Therapeutic Area

  • Oncology (ONC)

Disease

  • Primary central nervous system lymphoma

Biomarkers

  • N/A

Drug/Treatment

  • Methotrexate

  • Cytarabine liposomal

  • Rituximab

  • Thiotepa

Outcome

  • N/A

Study Design

  • Randomized

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved